Hbk Sorce Advisory LLC Organon & Co. Transaction History

Hbk Sorce Advisory LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $6,811 - $10,201	-318 Reduced 3.34%	9,208 $325,000
Q4 2022 Feb 09, 2023	BUY	$23.31 - $28.61 $222,051 - $272,538	9,526 New	9,526 $266,000
Q2 2022 Aug 15, 2022	SELL	$31.66 - $38.9 $197,558 - $242,736	-6,240 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $31,028 - $40,107	-1,019 Reduced 14.04%	6,240 $218,000
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $13,732 - $17,785	-479 Reduced 6.19%	7,259 $221,000
Q3 2021 Nov 15, 2021	BUY	$28.63 - $35.64 $221,538 - $275,782	7,738 New	7,738 $254,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

Stay updated on Hbk Sorce Advisory LLC with notifications on news.